Dr. Mohammed Naseer R Specialist Medical Oncology
Years of Experience : 10
Nationality : India
Languages Known : English, Hindi, Urdu, Kannada
Education & Training: MBBS, MD, DM (Medical Oncology), ECMO (European Certification in Medical Oncology), FIAP
Book AppointmentBiography
Dr. Mohammed is a highly accomplished medical oncologist dedicated to delivering ethical, compassionate, and scientifically advanced care to his patients. With a commitment to treating every patient as if they were a member of his own family, he focuses on providing holistic and personalized solutions for individuals battling cancer. His expertise spans both medical and pediatric oncology, and he remains deeply committed to staying at the forefront of innovative treatments while fostering a collaborative team approach. Dr. Mohammed has trained extensively at some of the most renowned medical institutions in India, gaining comprehensive experience in managing a wide range of adult and pediatric malignancies. He earned his MBBS from Bangalore Medical College and Research Institute (BMCRI), his MD from ESIPGIMSR (Andheri, Mumbai), and completed his DM in Medical Oncology at the prestigious Gujarat Cancer and Research Institute (GCRI) in Ahmedabad. Additionally, he holds a Fellowship in Pediatric Hematology and Oncology (FIAP) awarded by the Indian Academy of Pediatrics (IAP) and is a certified medical oncologist with the European Society for Medical Oncology (ESMO). After completing his DM, Dr. Mohammed joined Health Care Global (HCG) in Bangalore, India’s largest private cancer care provider. For over four years, he has been an integral member of their core oncology team. His work primarily involves managing solid tumors and hematolymphoid malignancies, with a special interest in thoracic malignancies, particularly lung cancer.
Presentations in International Conferences
- Poster Presentation: Pulsed versus single-shot immune-amplified 1 Gy minuscule radiotherapy synchronic with immune-checkpoint inhibitors and SBRT in disseminated malignancies. Immuno-RT (i-RT) concept to reprogram the microenvironment for inducing in-situ vaccination.
Presented at ASTRO, Washington, DC, September 24. - Poster Presentation: Identification of clinically actionable biomarkers in an Indian cancer cohort using comprehensive genomic profiling (CGP): An institutional experience. Presented at ASCO, Chicago, June 2023.
- Poster Presentation: Molecular epidemiology of EGFR mutations in NSCLC: A single-center experience from India. Presented at the European Lung Cancer Congress (ELCC), Copenhagen, Denmark, March–April 2023.
- Poster Presentation: Sustained response with PDL-1 inhibitor (Pembrolizumab) and KRAS G12C mutation-positive inhibitor (Sotarasib) in a case of metastatic squamous cell carcinoma with brain metastases. Young Oncologist Poster Presentation, ESMO Asia, Singapore, FPN Y023, December 2023.
- Poster Presentation: Insights into clinically actionable biomarkers in an Indian cancer cohort of 1000 patients using comprehensive genomic profiling (CGP): A single-institution experience. Presented at ESMO Asia, Singapore, December 2023.
- Poster Presentation: Comprehensive genomic profiling (CGP) unravels somatic BRCA (sBRCA) and homologous recombination repair (HRR) gene alterations. Presented at ESMO Asia, Singapore, December 2023.
- Poster Presentation: Comprehensive genomic profiling (CGP) unravels druggable targets in breast carcinoma (BC): A single-institution experience. Presented at ESMO Asia, Singapore, December 2023.
- Poster Presentation: Immune checkpoint inhibitors (ICIs) in cancer therapy: An experience from a resource-poor and developing country. ESMO Virtual Immuno-Oncology Conference, December 2020.
- Poster Presentation: Cancer immunotherapy: A single-center experience from western India. Presented at the 2nd World Congress on Excellence in Oncology Care (EIOC), Dubai, UAE, October 2019.
- Oral Presentation: A rare demon—Dengue fever in febrile neutropenia. Presented at the 12th World Congress of the International Society of Pediatric Oncology (SIOP) Asia, Bangkok, May 2017.
- Poster Presentation: Acute myeloid leukemia: Correlation of cytogenetics and outcome in a tertiary care pediatric center. Presented at the 49th World Congress of the International Society of Pediatric Oncology (SIOP), Washington, DC, September 2017.
Oral Presentations in National Conferences
- Cancer Immunotherapy: A single-center experience from western India. Presented at the Immune-Oncology Conference (I-OSICON), Mumbai, March 2019.
Poster Presentations in National Conferences
- Newer Drugs in the Treatment of Metastatic Breast Carcinoma: A single-center experience from western India. Presented at the 2nd Annual Indian Breast Cancer Conference, Jaipur, October 2018.
- Role of TDM-1 in Metastatic Breast Cancer: A case report. Presented at the 2nd Annual Indian Breast Cancer Conference, Jaipur, October 2018.
- CDK Inhibitors in the Treatment of Breast Cancer: A case series from a tertiary care center in western India. Presented at the 2nd Annual Indian Breast Cancer Conference, Jaipur, October 2018.
- Clinical Profile and Outcome of Patients with Primary CNS Lymphoma: A single-center experience from western India.
Research & Publications
- Identification of Clinically Actionable Biomarkers in an Indian Cancer Cohort Using Comprehensive Genomic Profiling (CGP): An Institutional Experience ASCO 2023. JCO 41, e15166-e15166 (2023). DOI: 10.1200/JCO.2023.41.16_suppl.e15166.
- Insights into Clinically Actionable Biomarkers in an Indian Cancer Cohort of 1000 Patients Using Comprehensive Genomic Profiling (CGP) (Best Poster) ESMO Asia 2023. Annals of Oncology 34 (suppl_4): S1623-S1631. DOI: 10.1016/annonc/annonc1387.
- Comprehensive Genomic Profiling (CGP) Unravels Druggable Targets in Breast Carcinoma (BC): A Single-Institutional Experience ESMO Asia 2023. Annals of Oncology 34 (suppl_4): S1485-S1493. DOI: 10.1016/annonc/annonc1376.
- Comprehensive Genomic Profiling (CGP) Unravels Somatic BRCA (sBRCA) and Homologous Recombinant Repair (HRR) Gene Alterations ESMO Asia 2023. Annals of Oncology 34 (suppl_4): S1623-S1631. DOI: 10.1016/annonc/annonc1387.
- Molecular Epidemiology of EGFR Mutations in NSCLC: A Single-Center Experience from India Prevention, Early Detection, Epidemiology, Tobacco Control, Volume 18, Issue 4, Supplement S123-S124, April 2023. DOI: 10.1016/S1556-0864(23)00407-0.
- Flagging the Merited Lesions: Cancer-Associated Fibroblast 1a and 4 Signaled Molecular Imaging to Map Key Avid Domains for Spiked Antigenicity Using SBRT In Situ Vaccination and Metronomic Radiation for Immunoproteination with Anti-PDL-1 Immunotherapy for Augmented Abscopal and Radscopal Responses in Disseminated Cancers International Journal of Radiation OncologyBiologyPhysics 114(3): e432, November 2022. DOI: 10.1016/j.ijrobp.2022.07.1641.
- Immune Checkpoint Inhibitors (ICIs) in Cancer Therapy: An Experience from a Resource-Poor and Developing Country Annals of Oncology, December 2020, Vol 31 (suppl_7): S1440. DOI: 10.1016/j.annonc.2020.10.548.
- Cancer Immunotherapy: A Tertiary Care Center Experience from Western India Journal of Immunotherapy and Precision Oncology (2019) 2 (3): 106–125. DOI: 10.4103/2666-2345.265156.
- Myeloid Sarcoma: Case Series and Literature Review GCSMC Journal of Medical Science, Vol IX, No I, January–June 2020.
- Targeted Therapy: Vemurafenib in BRAF V600E Positive Langerhans Cell Histiocytosis Pediatric Hemato-Oncology Journal. DOI: 10.1016/j.phoj.2017.11.040.
- Acute Myeloid Leukemia: Correlation of Cytogenetics and Outcome in a Resource-Limited Setting Pediatric Hemato-Oncology Journal. DOI: 10.1016/j.phoj.2017.11.057.
- Clinical Profile of Children with Hodgkin Lymphoma: Tertiary Care Experience Pediatric Hemato-Oncology Journal. DOI: 10.1016/j.phoj.2017.11.045.
- A Rare Demon: Dengue Fever in Febrile Neutropenia of Pediatric Malignancy Pediatric Hemato-Oncology Journal. DOI: 10.1016/j.phoj.2017.11.139.
- Profile of Bloodstream Infections in Pediatric Cancer Patients at a Tertiary Care Center Pediatric Hemato-Oncology Journal. DOI: 10.1016/j.phoj.2017.11.090.
- Pediatric Autoimmune Hemolytic Anemia: A Case Series Pediatric Hemato-Oncology Journal. DOI: 10.1016/j.phoj.2017.11.059.
- Bone Marrow Necrosis as a Rare Presentation of Malignancy Pediatric Hemato-Oncology Journal. DOI: 10.1016/j.phoj.2016.10.098.
- An Unusual Case of Langerhans Cell Histiocytosis in a Neonate Pediatric Hemato-Oncology Journal. DOI: 10.1016/j.phoj.2016.10.095.
- Multiple Pathological Fractures as a Presentation in an 18-Month-Old Child with Sickle Cell Disease Pediatric Hemato-Oncology Journal. DOI: 10.1016/j.phoj.2016.10.104.
Expertise
- Thoracic Cancers- Lung cancer.
- Chemotherapy, Targeted therapy, Hormone therapy, Immunotherapy.
- Breast Cancer.
- Gynecologic Malignancies- Gestational Trophoblastic disease, Ovarian, Uterine, Vulvar cancer.
- Gastrointestinal Malignancies and Hepato biliary malignancies- Oesophageal, gastric, Liver, periampullary, pancreatic colon and rectal cancer.
- Urothelial Malignancies- Kidney, Bladder, Prostrate and Testicular Cancers.
- Head and Neck cancers.
- Bone cancers- Osteosarcoma, Ewing sarcoma/Primitive Neuroectodermal Tumour and others.
- Sarcomas- Soft tissue sarcomas, Gastrointestinal Stromal Tumour (GIST), Rhabdomyosarcoma.
- Endocrine Malignancies- Neuroendocrine Tumours, Thyroid malignancies, Adrenal tumours.
- Hematolymphoid disorders- Lymphomas- Hodgkin and Non Hodgkin Lymphoma. Chronic Myeloid Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL).
- Multiple Myeloma.
- Hematological Disorders- Aplastic Anemia, Idiopathic Thrombocytopenic Purpura, Thalassemia, Nutritional anemi.
- Childhood Malignancies- Childhood ALL, AML, CML, Wilms Tumours, Neuroblastoma.
- Retinoblastoma, Medulloblastoma.
